(3.145.63.136)
Users online: 8287     
Ijournet
Email id
 

Indian Journal of Forensic Medicine & Toxicology
Year : 2019, Volume : 13, Issue : 4
First page : ( 289) Last page : ( 295)
Print ISSN : 0973-9122. Online ISSN : 0973-9130.
Article DOI : 10.5958/0973-9130.2019.00305.0

Assessment of Breast Tumors among Iraqi women at Women Health Center in Baghdad City: Comparative Study

Ghafel Hawraa Hussein1, Tuffah Wafaa2

1Lecturer at, Maternal and Neonate Nursing Department, College of Nursing, University of Baghdad

2Academic Maternity Nurse, AL-Elwaya Maternity Hospital at Baghdad City

Online published on 27 November, 2019.

Abstract

Objective

This study conducted to assess the breast tumors among Iraqi women and to comparison between benign and malignancy tumors

Methodology

This study conducted at (Women Health Center) for early detection of breast cancer in Baghdad City for (100) women that visit the center. The study was started in June 2018 to March 2019. The data regarding breast tumors was achieved from the patients directly throw the interview and some of the data was achieved from patient's chart.

Results

The results reported that malignancy tumors among Iraqi women was (35%) of the total sample and (65%) were benign, while in the worldwide (20%) of breast tumors are malignancy and (80%) benign.

Conclusions

The present study has come out with the following conclusions; although low percentage of Iraqi women where have malignancy breast tumors but the percent is high when comparison with incidence of the malignancy breast tumors in the worldwide. Breast cancer has become a major threat to female life in Iraq.

Top

Keywords

Breast Tumors, Benign Tumors, Malignancy Tumors, Comparative Study.

Top

 
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
740,650,730 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.